EMEA-002146-PIP02-18 - paediatric investigation plan
Palbociclib
PIPHuman
Pfizer Europe MA EEIG
Tel. +44 1304 6466 07
E-mail: pip_enquiries@pfizer.com
P/0005/2019: EMA decision of 3 January 2019 on the granting of a product specific waiver for palbociclib (IBRANCE) (EMEA-002146-PIP02-18)